The TOCOL and TOROW functions are just two ways to rearrange data in Microsoft Excel. For example, you can flip the rows and ...

Semrush Holdings, Inc. ( NYSE: SEMR) Goldman Sachs Communicopia + Technology Conference 2025 September 8, 2025 5:25 PM EDT ...

Performance becomes an issue with large datasets too. A poorly written macro can bog down Excel and take forever to complete, ...

(Gray News) - Google is advising billions of Gmail users to change their passwords and up their security following a data breach that prompted more aggressive hacking attacks. Earlier this month, ...

When it comes to top players heading into the final year of their contract, expect Real Madrid to be watching on to see how things unfold. The Spanish club have signed David Alaba, Kylian Mbappe, and ...

Stocks have been resilient since the July jobs report, with interest rate cuts now not just a hope but a legitimate expectation. Jay Powell gives his annual Jackson Hole speech this Friday, the last ...

Declan Humphreys serves on the Executive Committee of the Australian Chapter of the IEEE's Society for the Social Implications of Technology. In July, the United States government made it clear that ...

Bitmine Immersion Technologies (BMNR) stock ended Tuesday's trading session up more than 5% after ethereum (ETH-USD) rose another 6% to trade north of $4,500 and the company announced plans to sell up ...

Bitcoin BTC $114,507.12 bulls mounted a fresh challenge to a crucial resistance level as traders looked forward to U.S. inflation data. The top cryptocurrency rose to $122,056, testing the 1.618% ...

A security researcher said flaws in a carmaker’s online dealership portal exposed the private information and vehicle data of its customers, and could have allowed hackers to remotely break into any ...

Google is the latest company to suffer a data breach in an ongoing wave of Salesforce CRM data theft attacks conducted by the ShinyHunters extortion group. In June, Google warned that a threat actor ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 agonist, ...